InvestSMART

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.065

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Quarterly Activities Report and Appendix 4C 27 Oct 2026 8:22AM $0.065 $0.065 fallen by 0%
$23 Notice of Annual General Meeting/Proxy Form 26 Oct 2026 4:06PM $0.067 $0.065 fallen by 2.99%
$23 ColoSTAT Economic Study - Australian Public Health Savings 7 Oct 2026 9:10AM $0.078 $0.065 fallen by 16.67%
$23 Final Director's Interest Notice - Gavin Fox-Smith 30 Sep 2026 5:18PM $0.081 $0.065 fallen by 19.75%
$23 FY26 Appendix 4G and Corporate Governance Statement 29 Sep 2026 4:52PM $0.081 $0.065 fallen by 19.75%
$23 FY26 Annual Report 29 Sep 2026 4:51PM $0.081 $0.065 fallen by 19.75%
$23 AGM date and closing date for director nominations 29 Sep 2026 12:09PM $0.082 $0.065 fallen by 20.73%
$23 Board Changes 29 Sep 2026 8:11AM $0.083 $0.065 fallen by 21.69%
$23 Initial ColoSTAT Assessment in UK opens new market access 22 Sep 2026 8:24AM $0.082 $0.065 fallen by 20.73%
$23 Initial Director's Interest Notice - Carl Stubbings 28 Aug 2026 3:07PM $0.097 $0.065 fallen by 32.99%
$23 Initial Director's Interest Notice - Maureen Baker 28 Aug 2026 3:06PM $0.097 $0.065 fallen by 32.99%
$23 FY26 Appendix 4E & Audited Financial Report 27 Aug 2026 5:04PM $0.098 $0.065 fallen by 33.67%
$23 Appointment of Non-Executive Directors 26 Aug 2026 8:07AM $0.105 $0.065 fallen by 38.10%
$23 Notification of cessation of securities - RHY 21 Aug 2026 1:01PM $0.092 $0.065 fallen by 29.35%
$23 ColoSTAT Commercial Rollout Update 20 Aug 2026 8:40AM $0.082 $0.065 fallen by 20.73%
$23 Bioshares 2026 Presentation 6 Aug 2026 8:38AM $0.086 $0.065 fallen by 24.42%
$23 Quarterly Activities Report and Appendix 4C 30 Jul 2026 8:33AM $0.081 $0.065 fallen by 19.75%
$23 New Lung Cancer Genetype Risk Assessment Test 21 Jul 2026 8:30AM $0.086 $0.065 fallen by 24.42%
$23 Accreditation Matters Conference Presentation 7 Jul 2026 8:26AM $0.093 $0.065 fallen by 30.11%
$23 Rhythm launches tailored ColoSTAT marketing campaign 2 Jul 2026 8:24AM $0.100 $0.065 fallen by 35%
$23 Rhythm Bio Singapore Investor Presentation 4 Jun 2026 8:24AM $0.115 $0.065 fallen by 43.48%
$23 ColoSTAT Access Program Gains Momentum 26 May 2026 8:49AM $0.130 $0.065 fallen by 50%
$23 Investor Presentation 13 May 2026 10:08AM $0.135 $0.065 fallen by 51.85%
$23 ColoSTAT Demonstrates Early Clinical Adoption 6 May 2026 8:28AM $0.135 $0.065 fallen by 51.85%
$23 Investor Webinar 5 May 2026 11:04AM $0.130 $0.065 fallen by 50%

1 - 25 of 654 results

Page 1 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.